Jump to content

4-AcO-DPT

Edit links
From Wikipedia, the free encyclopedia
4-AcO-DPT
Names
Preferred IUPAC name
3-[2-(Diethylamino)ethyl]-1H-indol-4-yl acetate
Other names
Depracetin
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C18H26N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h6-8,13,19H,4-5,9-12H2,1-3H3
    Key: KRUGABVNKKKCJN-UHFFFAOYSA-N
  • CCCN(CCC)CCC1=CNC2=C1C(=CC=C2)OC(=O)C
Properties
C18H26N2O2
Molar mass 302.418 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

4-Acetyloxy-N,N-dipropyltryptamine (or 4-AcO-DPT) is a tryptamine derivative. 4-AcO-DPT has been sold as a designer drug.[1] It is an ester of 4-HO-DPT, a psychedelic tryptamine first synthesized by Alexander Shulgin. Anecdotal reports indicate that 4-AcO-DPT exerts psychoactive effects in humans, however, the pharmacology of 4-AcO-DPT has not been examined.[2][3]

See also

[edit]

References

[edit]
  1. ^ Schifano, Fabrizio; Orsolini, Laura; Papanti, Duccio; Corkery, John (2017). Neuropharmacology of new psychoactive substances (NPS) : the science behind the headlines. Current Topics in Behavioral Neurosciences. Vol. 32. Cham, Switzerland: Springer. pp. 351–380. doi:10.1007/978-3-319-52444-3. ISBN 978-3-319-52444-3. S2CID 23812562. Retrieved 14 January 2021.
  2. ^ Nervewing. "Greater Mind Lesser Body". Erowid Experience Vaults. Erowid. Retrieved 14 January 2021.
  3. ^ "Tihkal 4-HO-DIPT entry".


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=4-AcO-DPT&oldid=1099682253"